Transmissibility of adenovirus-induced adiposity in a chicken model
about
Human Adenovirus 36 Infection Increased the Risk of Obesity: A Meta-Analysis UpdateAdenovirus 36 and Obesity: An OverviewThe Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of ObesityE4orf1: a novel ligand that improves glucose disposal in cell cultureViral Infections and Obesity.Serological data analyses show that adenovirus 36 infection is associated with obesity: a meta-analysis involving 5739 subjects.Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies.Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids.Role of adenoviruses in obesity.A human adenovirus enhances preadipocyte differentiation.Harnessing the beneficial properties of adipogenic microbes for improving human health.Template to improve glycemic control without reducing adiposity or dietary fat.PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells.Pawnobiome: manipulation of the hologenome within one host generation and beyondObesity and its therapy: from genes to community actionLong-term changes in adiposity and glycemic control are associated with past adenovirus infection.Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling.Infectivity period of mice inoculated with human adenovirusesInsulin receptor-independent upregulation of cellular glucose uptakeMetabolically favorable remodeling of human adipose tissue by human adenovirus type 36.Acute effect of infection by adipogenic human adenovirus Ad36.Adenovirus-36 seropositivity and its relation with obesity and metabolic profile in children.Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells.Prophylactic and therapeutic vaccines for obesity.Infection-induced inflammatory response of adipocytes in vitro.New insights into how adenovirus might lead to obesity: An oxidative stress theory.Obesity and infection: two sides of one coin.Gene expression profile in human skeletal muscle cells infected with human adenovirus type 36.An infection of human adenovirus 31 affects the differentiation of preadipocytes into fat cells, its metabolic profile and fat accumulation.Adenovirus type 9 enhances differentiation and decreases cytokine release from preadipocytes.Adipogenic cascade can be induced without adipogenic media by a human adenovirus.The relationship between adenovirus-36 seropositivity, obesity and metabolic profile in Turkish children and adults.Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study.Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesityReduction of adenovirus 36-induced obesity and inflammation by mulberry extract.Lack of adenovirus DNA in mediastinal adipose tissue of obese/overweight adults with cardiovascular disorders?Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells.Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes.Human adenovirus-36 and childhood obesity.Virus-induced obesity.
P2860
Q26771963-0DC2C13E-3BCC-4950-A98D-D6F64188273AQ26799943-A8CE9C94-C108-4D81-AAC4-E2DB7EDE8A10Q28067835-12D69750-CF56-40CD-AA4A-CCAEF0D4265DQ28741118-E0F70FD5-0D23-4E4C-BB62-BA1FF75375D4Q30235298-7EE71980-CDDE-4C23-A19D-AFBAE81421A9Q30651817-3899A5C3-104D-49A7-B457-683B926FE133Q34359430-B0CB6D14-DEAA-4492-878A-E88C1409DE5BQ34378590-8FC25EFC-A6AB-4C94-9F88-F6FE6724E11FQ34493305-C999AA4E-E508-4EDF-99C2-271387D94C18Q34548223-A1819EDA-651E-4BE8-ACD5-D1220A4906EEQ34714843-366351DC-7BDC-4AA6-9F5E-47F3E95BFBD1Q34979386-81607FC0-7B90-41D5-A5C3-0806575A89A8Q35223008-1C3F0D21-3C49-438E-B0A8-86B58E344806Q35913977-7D117F01-5B20-4180-BF2C-C8A339098F93Q36549038-883CA10B-BC30-403B-91F7-22A5D70E2A37Q36629576-D18A8A36-FDB9-45A7-AFFA-E244FD88F907Q36756533-6FA8AAEA-2329-4AC3-9ED3-FE2D90A8DA41Q36817766-9CD336CA-CE6B-45DD-AD9A-369E858F00BFQ36826889-FADE2AE4-BB51-400E-81AC-571BDD119D91Q36842558-369C355B-03F7-4C4B-B08D-BCF9987FC620Q37347715-A767D73C-36A6-4A16-ACC0-17F413F639B1Q37353633-386A259C-4199-493A-8069-7E5EB0A580D7Q37354346-C424BE77-025E-45E6-A2A4-808ADD7AFD94Q37473523-03AAA211-9B53-46D9-829D-157AFAFFB210Q37857830-2B610A69-0702-4BAB-B557-79A288F975EBQ37880106-14CC17B9-0DC0-4CE5-AF11-DD312CAD4185Q38154513-D2A5FAE5-8872-459D-87CB-6B919EF36698Q38411386-888C924B-E913-446E-BF3D-9DB32372E1B6Q38841740-530B01AD-B616-4B2A-B656-511DE0F31C48Q38979652-9AF1F8D5-000F-4420-8544-BE58F76BDCD7Q39891667-2DD32FA7-0406-4FA5-9370-771F6C07E0D0Q41069406-ABB9AE8D-475E-4D1A-BAF2-10B3874A5E90Q41175787-3179B43F-A349-4D55-AFC3-2A99F6E9FEE8Q41915717-C7F198C0-B221-44FE-9848-B58ADA114299Q42234673-282D68F4-5A70-4F5A-8885-2A7453E590B4Q42255126-F3DDBE0B-A139-4C07-891C-BF7FCF0DE39EQ42801909-2A68E12F-1C69-4E8D-9D50-A6720B7ADB48Q42802641-939CFE73-D1B7-4BD8-9EA7-9AF9D666290BQ44156650-E82BE47D-EF4E-41A7-B3D7-5E4BA25BABC0Q45421630-C2B65E6B-532E-4F26-802E-686BCFD57C2F
P2860
Transmissibility of adenovirus-induced adiposity in a chicken model
description
article
@en
im Juli 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2001
@uk
name
Transmissibility of adenovirus-induced adiposity in a chicken model
@en
Transmissibility of adenovirus-induced adiposity in a chicken model
@nl
type
label
Transmissibility of adenovirus-induced adiposity in a chicken model
@en
Transmissibility of adenovirus-induced adiposity in a chicken model
@nl
prefLabel
Transmissibility of adenovirus-induced adiposity in a chicken model
@en
Transmissibility of adenovirus-induced adiposity in a chicken model
@nl
P2093
P2860
P356
P1476
Transmissibility of adenovirus-induced adiposity in a chicken model
@en
P2093
JM Kolesar
NV Dhurandhar
RL Atkinson
P2860
P2888
P304
P356
10.1038/SJ.IJO.0801668
P407
P577
2001-07-01T00:00:00Z